NEW YORK--(BUSINESS WIRE)--
The Board of Directors of Bristol-Myers
Squibb Company (NYSE:BMY) today declared a quarterly dividend of
forty cents ($0.40) per share on the $.10 par value Common Stock of the
corporation. The next quarterly dividend will be payable on November 1,
2018, to stockholders of record at the close of business on October 5,
2018.
The directors also declared a quarterly dividend of fifty cents ($0.50)
per share on the $2.00 Convertible Preferred Stock of the corporation,
payable December 3, 2018 to stockholders of record at the close of
business on November 6, 2018.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter,
YouTube
and Facebook.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20180912005819/en/
Bristol-Myers Squibb
Media:
Lisa McCormick
Lavery, 609-252-7602
lisa.mccormicklavery@bms.com
or
Investors:
Tim
Power, 609-252-7509
timothy.power@bms.com
or
Bill
Szablewski, 609-252-5894
william.szablewski@bms.com
Source: Bristol-Myers Squibb Company